From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males
Anti-Müllerian hormone (AMH), a biomarker secreted by Sertoli cells in the testes, has emerged as a critical indicator of male reproductive function with significant clinical application potential. AMH reflects Sertoli cell activity and plays a pivotal role across different stages of male gonadal fu...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-01-01
|
| Series: | Endocrine Connections |
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/14/3/EC-24-0630.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832539706549600256 |
|---|---|
| author | Yuanyuan Zeng Guicheng Zhao Yi Zheng Xiaohui Jiang |
| author_facet | Yuanyuan Zeng Guicheng Zhao Yi Zheng Xiaohui Jiang |
| author_sort | Yuanyuan Zeng |
| collection | DOAJ |
| description | Anti-Müllerian hormone (AMH), a biomarker secreted by Sertoli cells in the testes, has emerged as a critical indicator of male reproductive function with significant clinical application potential. AMH reflects Sertoli cell activity and plays a pivotal role across different stages of male gonadal function. First, in prepubertal males, AMH levels are crucial for assessing testicular development and the progression of puberty, with delayed or insufficient AMH secretion often being associated with disorders such as delayed puberty. Second, in reproductive-age males, AMH serves as an important biomarker for evaluating spermatogenic capacity, particularly in cases of idiopathic non-obstructive azoospermia. In these patients, AMH levels can help predict the success of testicular sperm extraction, thereby influencing fertility treatment strategies. This review explores the physiological mechanisms of AMH and its diagnostic and prognostic significance in both delayed puberty and fertility disorders in reproductive-age males. While AMH shows great promise in the management of hypogonadism, further research is needed to validate its clinical utility and refine treatment protocols for optimizing patient outcomes. |
| format | Article |
| id | doaj-art-b4a695054c134ee4a5cb04d42b935eb5 |
| institution | Kabale University |
| issn | 2049-3614 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Bioscientifica |
| record_format | Article |
| series | Endocrine Connections |
| spelling | doaj-art-b4a695054c134ee4a5cb04d42b935eb52025-02-05T10:16:05ZengBioscientificaEndocrine Connections2049-36142025-01-0114310.1530/EC-24-06301From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in malesYuanyuan Zeng0Guicheng Zhao1Yi Zheng2Xiaohui Jiang3Human Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaHuman Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaHuman Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaHuman Sperm Bank, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaAnti-Müllerian hormone (AMH), a biomarker secreted by Sertoli cells in the testes, has emerged as a critical indicator of male reproductive function with significant clinical application potential. AMH reflects Sertoli cell activity and plays a pivotal role across different stages of male gonadal function. First, in prepubertal males, AMH levels are crucial for assessing testicular development and the progression of puberty, with delayed or insufficient AMH secretion often being associated with disorders such as delayed puberty. Second, in reproductive-age males, AMH serves as an important biomarker for evaluating spermatogenic capacity, particularly in cases of idiopathic non-obstructive azoospermia. In these patients, AMH levels can help predict the success of testicular sperm extraction, thereby influencing fertility treatment strategies. This review explores the physiological mechanisms of AMH and its diagnostic and prognostic significance in both delayed puberty and fertility disorders in reproductive-age males. While AMH shows great promise in the management of hypogonadism, further research is needed to validate its clinical utility and refine treatment protocols for optimizing patient outcomes.https://ec.bioscientifica.com/view/journals/ec/14/3/EC-24-0630.xmlamhhypogonadismdelayed pubertyinoabtb |
| spellingShingle | Yuanyuan Zeng Guicheng Zhao Yi Zheng Xiaohui Jiang From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males Endocrine Connections amh hypogonadism delayed puberty inoa btb |
| title | From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males |
| title_full | From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males |
| title_fullStr | From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males |
| title_full_unstemmed | From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males |
| title_short | From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males |
| title_sort | from biological marker to clinical application the role of anti mullerian hormone for delayed puberty and idiopathic non obstructive azoospermia in males |
| topic | amh hypogonadism delayed puberty inoa btb |
| url | https://ec.bioscientifica.com/view/journals/ec/14/3/EC-24-0630.xml |
| work_keys_str_mv | AT yuanyuanzeng frombiologicalmarkertoclinicalapplicationtheroleofantimullerianhormonefordelayedpubertyandidiopathicnonobstructiveazoospermiainmales AT guichengzhao frombiologicalmarkertoclinicalapplicationtheroleofantimullerianhormonefordelayedpubertyandidiopathicnonobstructiveazoospermiainmales AT yizheng frombiologicalmarkertoclinicalapplicationtheroleofantimullerianhormonefordelayedpubertyandidiopathicnonobstructiveazoospermiainmales AT xiaohuijiang frombiologicalmarkertoclinicalapplicationtheroleofantimullerianhormonefordelayedpubertyandidiopathicnonobstructiveazoospermiainmales |